Skip to content

Supplier News

PepsiCo introduces aspartame-free Diet Pepsi

PepsiCo introduces aspartame-free Diet Pepsi

PepsiCo has unveiled aspartame-free Diet Pepsi as a new option for cola fans. “Diet cola drinkers in the U.S. told us they wanted aspartame-free Diet Pepsi, and we’re delivering,” said Seth Kaufman, senior vice president Pepsi and Flavors portfolio, PepsiCo North America Beverages.

Daymon Worldwide names new CEO

Daymon Worldwide names new CEO

Jim Holbrook has been appointed as chief executive officer at Daymon Worldwide, succeeding Carla Cooper, who is retiring. The consumables retail marketing firm said Thursday that Holbrook is slated to take the helm as CEO on Sept. 1. He also will join Daymon’s board of directors.

Aurobindo cleared to market Xanax generic

Aurobindo cleared to market Xanax generic

Aurobindo Pharma Ltd. has gained Food and Drug Administration approval for alprazolam tablets, a medication for anxiety. Aurobindo said its alprazolam product — available in dosages of 0.25 mg, 0.5 mg, 1 mg and 2 mg — is a generic version of Xanax tablets from Pfizer Inc. Part of a group of

DenTek launches e-commerce website

DenTek launches e-commerce website

DenTek has gone live with a new branded website featuring full e-commerce capabilities. The oral care brand said Monday that DenTek.com now provides oral care product information and tips plus the ability for consumers to buy items directly through the site.

Hikma to buy Roxane for $2.65 billion

Hikma to buy Roxane for $2.65 billion

Hikma Pharmaceuticals PLC, a fast growing multinational pharmaceutical group, plans to acquire Roxane Laboratories from Boehringer Ingelheim in a deal valued at $2.65 billion. Hikma said the agreement stands to transform its position in the U.S.